This is a significant savings over purchasing the 100 units by vial because this treatment is different than Botox injections used to create a cosmetic result, and therefore Botox purchased at this rate is only to be used for this treatment
Last Updated on April 22, 2026 When normal soreness and real warning signs are not the same thing See which post-injection symptoms usually settle quickly and which ones deserve prompt follow-up
Potential benefits of using GLP-1 receptor agonists after gastric sleeve surgery include: Enhanced weight loss : Observational studies suggest post-bariatric patients using GLP-1 receptor agonists may achieve additional weight reduction, typically around 510% of body weight, though individual responses vary considerably Improved glycaemic control : Particularly beneficial for patients with type 2 diabetes or prediabetes, as GLP-1 agonists enhance insulin secretion and reduce blood glucose levels Reduced appetite : These medications can help patients who struggle with persistent hunger despite surgical intervention Cardiovascular benefits : Semaglutide has demonstrated cardiovascular risk reduction in people with established cardiovascular disease, which may benefit eligible post-bariatric patients with this specific risk profile Maintenance of weight loss : May help prevent weight regain during the critical maintenance phase Potential risks and considerations include: Gastrointestinal side effects : Nausea, vomiting, diarrhoea, and constipation are common, particularly during dose escalation
When administered, Semaglutide activates GLP-1 receptors in the pancreas
